You just read:

Issuance of patent and initiation of a study to evaluate PMZ-1620 in dogs with degenerative myelopathy, a disease similar to human amyotrophic lateral sclerosis (ALS)

News provided by

Pharmazz, Inc.

Jan 11, 2018, 04:00 ET